Women in Polish otorhinolaryngology

2021 ◽  
Vol 10 (1) ◽  
Author(s):  
Antoni Bruzgielewicz ◽  
Robert Bartoszewicz ◽  
Dariusz Kaczmarczyk ◽  
Kazimierz Niemczyk

The first woman with a doctor's degree to practice in Poland was Anna Tomaszewicz-Dobrska (1854-1918). In Polish literature it is difficult to establish which of the women was the first to deal with diseases in the field of otorhinolaryngology. Pioneers in the specialty of otorhinolaryngology could be women who graduated from medical studies and completed "specialization" in clinics outside Poland or in Krakow, where the first department was established in Poland, and women were the first to have the opportunity to study medicine. In Poland, in 1925, out of 738 female doctors, only 4 of them dealt with diseases in the area of the head and neck, in 1938 21 women out of 2018 female doctors, and in 2020 out of 90,435 women, 1991 out of 3,378 doctors practicing the otorhinolaryngology. In Poland, Aleksandra Salomea Mitrinowicz-Modrzejewska was probably the first female otorhinolaryngologist who obtained her habilitation in 1947 and riched the title of associate professor in 1954. Until now, it has been established that only 28 women in Poland associated with otorhinolaryngology who have obtained the full profesor title.

1930 ◽  
Vol 26 (9) ◽  
pp. 945-946
Author(s):  
О. A. German

Scientific meetings of doctors of the State Institute for Advanced Medical Studies named after V.I. Lenin in Kazan. 121st meeting May 20, 1930 Privat Associate Professor O. A. German. Bacteriological examination of blood in endocarditis lent a and other septic diseases.


2019 ◽  
Vol 476 (24) ◽  
pp. 3705-3719 ◽  
Author(s):  
Avani Vyas ◽  
Umamaheswar Duvvuri ◽  
Kirill Kiselyov

Platinum-containing drugs such as cisplatin and carboplatin are routinely used for the treatment of many solid tumors including squamous cell carcinoma of the head and neck (SCCHN). However, SCCHN resistance to platinum compounds is well documented. The resistance to platinum has been linked to the activity of divalent transporter ATP7B, which pumps platinum from the cytoplasm into lysosomes, decreasing its concentration in the cytoplasm. Several cancer models show increased expression of ATP7B; however, the reason for such an increase is not known. Here we show a strong positive correlation between mRNA levels of TMEM16A and ATP7B in human SCCHN tumors. TMEM16A overexpression and depletion in SCCHN cell lines caused parallel changes in the ATP7B mRNA levels. The ATP7B increase in TMEM16A-overexpressing cells was reversed by suppression of NADPH oxidase 2 (NOX2), by the antioxidant N-Acetyl-Cysteine (NAC) and by copper chelation using cuprizone and bathocuproine sulphonate (BCS). Pretreatment with either chelator significantly increased cisplatin's sensitivity, particularly in the context of TMEM16A overexpression. We propose that increased oxidative stress in TMEM16A-overexpressing cells liberates the chelated copper in the cytoplasm, leading to the transcriptional activation of ATP7B expression. This, in turn, decreases the efficacy of platinum compounds by promoting their vesicular sequestration. We think that such a new explanation of the mechanism of SCCHN tumors’ platinum resistance identifies novel approach to treating these tumors.


Anaesthesia ◽  
2000 ◽  
Vol 55 (8) ◽  
pp. 814-814 ◽  
Author(s):  
R. M. Dravid ◽  
M. Popat
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document